<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>FDA Advisory Committee on FinanClub</title>
    <link>https://finan.club/tags/fda-advisory-committee/</link>
    <description>Recent content in FDA Advisory Committee on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Wed, 17 Apr 2024 09:09:09 +0000</lastBuildDate><atom:link href="https://finan.club/tags/fda-advisory-committee/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title>GERN</title>
      <link>https://finan.club/us/gern/</link>
      <pubDate>Wed, 17 Apr 2024 09:09:09 +0000</pubDate>
      
      <guid>https://finan.club/us/gern/</guid>
      <description>score:7
Chances: Geron Corporation&amp;rsquo;s stock is soaring after receiving positive news from the FDA Advisory Committee for its pipeline candidate, imetelstat. The company&amp;rsquo;s therapeutic product development in oncology and its telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies show promising potential for growth. Risks: The company recently announced an underwritten offering, which may dilute the value of existing shares and impact the stock price in the short term.</description>
    </item>
    
  </channel>
</rss>
